Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, Bence-Bruckler I, Birch P, Bredeson C, Chen J, Fergusson D, Halpenny M, Hamelin L, Huebsch L, Hutton B, Laneuville P, Lapierre Y, Lee H, Martin L, McDiarmid S, Oâ€™Connor P, Ramsay T, Sabloff M, Walker L, Freedman MS. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet 2016;388(10044):576â€“85.
Dowlatshahi D, Brouwers HB, Demchuk AM, Hill MD, Aviv RI, Ufholz LA, Reaume M, Wintermark M, Hemphill JC 3rd, Murai Y, Wang Y, Zhao X, Wang Y, Li N, Sorimachi T, Matsumae M, Steiner T, Rizos T, Greenberg SM, Romero JM, Rosand J, Goldstein JN, Sharma M. Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time. Stroke 2016;47(3):695â€“700.
Chardon JW, Smith AC, Woulfe J, Pena E, Rakhra K, Dennie C, Beaulieu C, Huang L, Schwartzentruber J, Hawkins C, Harms MB, Dojeiji S, Zhang M; FORGE Canada Consortium., Majewski J, Bulman DE, Boycott KM, Dyment DA.LIMS2 mutations associated with novel muscular dystrophy with triangular tongues. Clin Genet 2015;88(6):558â€“564.
Mestre TA, Lang AE, Okun MS. Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects. Mov Disord 2016;31(3):290â€“6.
Rush C, MacLean HJ, Freedman M. Aggressive multiple sclerosis: proposed definition and treatment algorithm. Nat Rev Neurol 2015;11(7):379â€“389.
Schlossmacher MG (PI), CIHR: Project Grant. A Role for LRRK2 and SNCA in Microbial Infections ($1,340,000)
Schlossmacher MG (PI), Michael J Fox Foundation: Tools for Parkin. To finance a partnership with BioLegend raising and commercializing immunoassays for Parkin. (US $200,000)
Maclean H. Educational Initiatives in Residency Education. â€śElectronic learning in clinical neuroscience: Does e-learning facilitate resident education? ($25,864)
Schlossmacher MG (PI) CIHR: To support MD/PhD students at the University of Ottawa ($138,000)
Mestre, Tiago (PI). Parkinson Research Consortium. A randomized, placebo-controlled, 2-arm parallel-group superiority phase II study of Glycopyrrolate for moderate-to-severe qsialorrhea in Parkinsonâ€™s disease ($50,000.00)
The Division of Neurology at Ottawa’s Department of Medicine is pursuing a vision for growth by focusing on three key areas of subspecialty interest: Stroke, Movement Disorders and Multiple Sclerosis. Each specialty area is rooted in a strong dedication and state-of-the-art expertise in the care of our patients, complemented by active multidisciplinary clinical research and closely linked to basic neuroscience research at the University level. Â The Division of Neurology has achieved considerable success in research productivity, publications, and grant funding â€“ while keeping a clear focus on our duty to both patients and community. In the past few years, the Division of Neurology has been successful in recruiting several high tier clinician scientists and dedicated clinical teachers. Â This has also been an exciting time of consolidation of resources in entirely renovated facilities: neuroscience clinic and office space, clinical teaching unit and stroke clinic.
Clinician investigators in the Division of Neurology combine with basic neuroscientists in the Ottawa Hospital Research Institute and the Faculty of Medicine at the University of Ottawa to form one of the strongest translational research groups in brain research in Canada. Areas of specific strength in clinical research are in multiple sclerosis, Parkinsonâ€™s disease and cerebrovascular disease.
The Division of Neurology cherishes its mandate in medical education, in close partnership with the University of Ottawa, at both the undergraduate and graduate levels. Â The residency program has tripled in size over the past 5 years, and has continued to enjoy a perfect record of success at national exams for two decades. Our residents enjoy the atmosphere of collegiality, and our vibrant enthusiasm for learning in a rich clinical and academic environment.
The Division of Neurology has maintained the highest standing in general clinical neurology consultation service in addition to offering a full complement of subspecialty clinics : Stroke, Parkinsonâ€™s and Movement Disorders, Multiple Sclerosis, Neuromuscular Diseases, Epilepsy, Memory Disorders. There are affiliated clinical neurophysiology laboratories (EEG, EMG, EP, intensive monitoring) as well as Neurovascular Doppler. We have strong links with well integrated Neuroradiology, Neurosurgery, Neuro-ophthalmology and Neuropsychology divisions. Patients are admitted to the clinical teaching unit, where a strong multidisciplinary care plan has been developed, or to a state of the art Neuro-Observation area.
Neurology inpatient and outpatient services are located mainly at the Civic Campus, with a number of specialty clinics situated at the General Campus.
THE OTTAWA HOSPITAL, CIVIC CAMPUS, 1053 Carling Avenue, OttawaÂ ONÂ K1Y 4E9
THE OTTAWA HOSPITAL, GENERAL CAMPUS, 501 Smyth Road, Ottawa ONÂ K1H 8L6
For a complete list of neurology clinic locations and contact information, CLICK HERE.